Iovance Biotherapeutics, Inc. | ||||
NGM : IOVA || Location: United States | ||||
$14.1+0.05 (+0.36%) |
4.11 M | 13.75 - 14.32 | ||
Last Updated:America/New_York | Volume | Day range |
Short Interest
Short Date | Short Interest |
---|---|
March 15, 2024 | 47.430 M |
Feb. 29, 2024 | 46.706 M |
Feb. 15, 2024 | 42.976 M |
Jan. 31, 2024 | 41.967 M |
Jan. 12, 2024 | 43.272 M |
EPS Surprise
Period | Estimate | Actual | Surprise |
---|---|---|---|
12/31/2023 | -0.44 | -0.45 | -2.23% |
09/30/2023 | -0.46 | -0.46 | 0.73% |
06/30/2023 | -0.81 | -0.47 | 42.15% |
03/31/2023 | -0.76 | -0.50 | 34.19% |
12/31/2022 | -0.65 | -0.64 | 1.52% |
Sector | Healthcare | Industry | Biotechnology |
Shares Outstanding | 278.932M | Shares Float | 210.919M |
Short Float | 47.430M | Market Cap | 3932.94M |
Institution ownership | 89.20% | Insider ownership | 0.561% |
Earnings Date | 05/07/2024 AMC | Cash Per Share | ? |
Trailing EPS | -1.89 | Forward EPS | -0.71 |